N80.A1

Clinical Causes: Hormonal fluctuations that influence the growth of endometrial tissue Retrograde menstruation, where menstrual blood containing endometrial cells flows backward into the pelvic cavity Genetic predisposition affecting immune system regulation of endometrial tissue Previous pelvic surgeries, which may facilitate the spread of endometrial tissue to abnormal locations Embryonic cell remnants that develop into endometrial tissue outside the uterus

Key Symptoms: Painful urination, especially during menstruation Pelvic or lower abdominal pain Frequent urination or urgency Lower back pain Blood in the urine (hematuria), often visible during menstrual periods Discomfort during sexual intercourse

Diagnosis Path: The diagnosis involves a combination of medical history review, physical examinations, and specific imaging tests. Cystoscopy, a procedure where a thin tube with a camera is inserted into the bladder, allows direct visualization of abnormal tissue. Additionally, imaging techniques like ultrasound, MRI, or CT scans may help evaluate the extent of the condition. Sometimes, a biopsy is performed during cystoscopy to confirm the presence of endometrial tissue on the bladder surface. It’s important for healthcare providers to differentiate superficial endometriosis from other bladder conditions to determine the appropriate treatment approach.

Treatment Protocols: Treatment options aim to relieve symptoms and prevent progression. These may include hormonal therapies such as contraceptives, gonadotropin-releasing hormone (GnRH) agonists, or progestins to suppress endometrial tissue growth. Other approaches include minimally invasive surgical procedures to remove or ablate endometrial lesions from the bladder surface. Pain management with medications may also be recommended. The choice of treatment is tailored to the individual's symptoms, reproductive plans, and overall health, often requiring a multidisciplinary approach involving gynecologists and urologists.